表紙:世界の画像診断市場
市場調査レポート
商品コード
903056

世界の画像診断市場

Diagnostic Imaging

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 537 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

世界の画像診断市場
出版日: 2021年05月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 537 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の画像診断市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

  • 市場概要
    • 画像診断市場が着実に成長
    • 世界の市場シェアシナリオ
    • セグメント別市場シェア
    • 核画像
    • CT
    • MRI
    • 超音波
    • X腺
  • 注目企業
  • 市場動向と促進因子
    • 高齢化
    • 心血管疾患、癌、慢性疾患の発症率上昇
    • 米国の癌統計
    • MRIシステムが市場を独占
    • ハイブリッドPET/MRI
    • 医療用X線システム
    • CTスキャニング市場
    • 技術革新
    • 放射線技師以外が多くの診断検査を実施
    • AIによる医療用画像の進歩
  • 世界市場見通し

第3章 市場分析

  • 地域別市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • アジア太平洋地域
  • オーストラリア
  • インド
  • 韓国
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • 中東
  • イラン
  • イスラエル
  • アラブ首長国連邦
  • アフリカ

第4章 競合

  • CARESTREAM HEALTH
  • ESAOTE SPA
  • 富士フイルムホールディングス株式会社
  • HITACHI LTD.
  • KONINKLIJKE PHILIPS NV
  • SAMSUNG MEDISON
  • 株式会社島津製作所
  • SIEMENS HEALTHINEERS
  • 東芝メディカルシステムズ株式会社

第5章 関連調査

目次
Product Code: MCP11515

Abstract:

Global Diagnostic Imaging Market to Reach US$48.5 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Diagnostic Imaging estimated at US$33.5 Billion in the year 2020, is projected to reach a revised size of US$48.5 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027.X-ray Imaging, one of the segments analyzed in the report, is projected to grow at a 5.3% CAGR to reach US$15.5 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the MRI segment is readjusted to a revised 5.4% CAGR for the next 7-year period. This segment currently accounts for a 18.9% share of the global Diagnostic Imaging market.

The U.S. Accounts for Over 27.1% of Global Market Size in 2020, While China is Forecast to Grow at a 8.2% CAGR for the Period of 2020-2027

The Diagnostic Imaging market in the U.S. is estimated at US$9.1 Billion in the year 2020. The country currently accounts for a 27.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$10.1 Billion in the year 2027 trailing a CAGR of 8.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR while Rest of European market (as defined in the study) will reach US$10.1 Billion by the year 2027.

Ultrasound Segment Corners a 20.8% Share in 2020

In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.3 Billion in the year 2020 will reach a projected size of US$7.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.5 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period.

Select Competitors (Total 66 Featured) -

  • Carestream Health, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Diagnostic Imaging - A Prelude
    • Global Diagnostic Imaging Market Set for a Strong Growth
    • Developed Regions: The Dominant Markets for Diagnostic Imaging
    • Developing Regions Exhibit the Fastest Growth
    • Increase in Number of Hospitals & Clinics Infuses Momentum in Developing Regions
    • Key Players
    • Segment Analysis
    • MRI Dominates the Global Diagnostic Imaging Market
    • EXHIBIT 1: Equipment Density Correlates With Number of Imaging Procedures: Magnetic Resonance Imaging (MRI) Units in Select Countries (Per Million Population) for the Year 2019
    • Global MRI Market by Application (2019): Percentage Breakdown of Procedure Volume for Brain, Cardiac & Vascular, Extremities, Full Body, Mammography, Spine and Others
    • Computed Tomography System (CT Scanner)
    • Ultrasound
    • EXHIBIT 2: Global Ultrasound Systems Market by Portability Type (2019): Percentage Breakdown of Unit Sales for Cart Systems and Point-of Care Systems
    • X-Ray
    • Nuclear Medicine
    • SPECT Dominates the Nuclear Medicine Market
    • Worldwide Installed Base of Nuclear Imaging Equipment by Modality (2019): Percentage Breakdown of Units Installed for PET and SPECT
  • PET
  • 2. FOCUS ON SELECT PLAYERS
    • Agfa-Gevaert N.V. (Belgium
    • Canon Medical Systems Corporation (Japan)
    • Carestream Health, Inc. (USA)
    • Esaote S.p.A. (Italy)
    • Fujifilm Corporation (Japan)
    • GE Healthcare (UK)
    • Koninklijke Philips N.V. (Netherlands)
    • Konica Minolta Inc. (Japan)
    • Hitachi Ltd. (Japan)
    • Hologic, Inc. (USA)
    • HOYA Group Pentax (Japan)
    • Samsung Medison Co., Ltd. (Korea)
    • Shimadzu Corporation (Japan)
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China
    • Siemens Healthineers (Germany)
  • 3. MARKET TRENDS & DRIVERS
    • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
    • Rapidly Aging Population Spurs Demand for Diagnostic Imaging: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
    • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
    • Rising Prevalence of Chronic Diseases Amplifies the Volume of Diagnostic Imaging Procedures: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
    • Rising Healthcare Expenditure Impels Global Market
    • Oncology Diagnostic Imaging to Witness Rapid Growth
    • Global Cancer Incidence by Type: 2018
    • Technological Innovations Drive the Global Diagnostic Imaging Market
    • Growing Adoption of Hybrid Diagnostic Imaging Modalities
    • PET-CT: The Most Successful Fusion Imaging Technique
  • SPECT-CT
    • PET/MRI Continues to Makes Inroads
    • Ultrasound and MRI Imaging: An Efficient Combination
    • Rapid Adoption of Contrast-Enhanced Ultrasound (CEUS) Drives Market Growth
    • CT Imaging Gains Popularity
    • CCTA Gaining Traction in Coronary Arteries Imaging
  • USE OF BLOCKCHAIN IN DIAGNOSTIC IMAGING
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Diagnostic Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for X-ray Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for X-ray Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 40: Japan Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 43: Japan Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 46: China Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 49: China Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 52: Europe Current & Future Analysis for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Diagnostic Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 61: France Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 64: France Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 67: Germany Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 70: Germany Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 73: Italy Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 76: Italy Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 79: UK Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 82: UK Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 85: Spain Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Spain Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Spain 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 88: Spain Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Spain Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Spain 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 91: Russia Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Russia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Russia 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 94: Russia Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Russia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Russia 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 97: Rest of Europe Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of Europe Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of Europe 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 100: Rest of Europe Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of Europe Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of Europe 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 103: Asia-Pacific Current & Future Analysis for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 104: Asia-Pacific Historic Review for Diagnostic Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Asia-Pacific 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 106: Asia-Pacific Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 109: Asia-Pacific Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Asia-Pacific 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 112: Australia Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Australia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Australia 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 115: Australia Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Australia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 117: Australia 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 118: India Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 119: India Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 120: India 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 121: India Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: India Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 123: India 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 124: South Korea Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 125: South Korea Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 126: South Korea 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 127: South Korea Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 128: South Korea Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 129: South Korea 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 130: Rest of Asia-Pacific Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Asia-Pacific 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Asia-Pacific Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Asia-Pacific Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Asia-Pacific 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 136: Latin America Current & Future Analysis for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 137: Latin America Historic Review for Diagnostic Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 138: Latin America 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 139: Latin America Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 142: Latin America Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 144: Latin America 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 145: Argentina Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Argentina Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 147: Argentina 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 148: Argentina Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Argentina Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 150: Argentina 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 151: Brazil Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Brazil Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 153: Brazil 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 154: Brazil Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Brazil Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 156: Brazil 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 157: Mexico Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Mexico Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 159: Mexico 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 160: Mexico Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Mexico Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 162: Mexico 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 163: Rest of Latin America Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Rest of Latin America Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 165: Rest of Latin America 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 166: Rest of Latin America Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Rest of Latin America Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 168: Rest of Latin America 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 169: Middle East Current & Future Analysis for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 170: Middle East Historic Review for Diagnostic Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 171: Middle East 15-Year Perspective for Diagnostic Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 172: Middle East Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 175: Middle East Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 177: Middle East 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 178: Iran Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Iran Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 180: Iran 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 181: Iran Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Iran Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 183: Iran 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 184: Israel Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Israel Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 186: Israel 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 187: Israel Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Israel Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 189: Israel 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 190: Saudi Arabia Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Saudi Arabia Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 192: Saudi Arabia 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 193: Saudi Arabia Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Saudi Arabia Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 195: Saudi Arabia 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 196: UAE Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 197: UAE Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 198: UAE 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 199: UAE Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 200: UAE Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 201: UAE 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 202: Rest of Middle East Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Rest of Middle East Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 204: Rest of Middle East 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 205: Rest of Middle East Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Rest of Middle East Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 207: Rest of Middle East 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 208: Africa Current & Future Analysis for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Africa Historic Review for Diagnostic Imaging by Product - X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 210: Africa 15-Year Perspective for Diagnostic Imaging by Product - Percentage Breakdown of Value Sales for X-ray Imaging, MRI, Ultrasound, CT and Nuclear Imaging for the Years 2012, 2020 & 2027
    • TABLE 211: Africa Current & Future Analysis for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Africa Historic Review for Diagnostic Imaging by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 213: Africa 15-Year Perspective for Diagnostic Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 66